A cross-sectional analysis of the short-term outcomes of patients receiving prehospital treatment for symptomatic hypoglycaemia in Cape Town  by Ridhaa Booley, Mohamed & Welzel, Tyson
African Journal of Emergency Medicine (2015) 5, 159–164African Federation for Emergency Medicine
African Journal of Emergency Medicine
www.afjem.com
www.sciencedirect.comORIGINAL RESEARCH ARTICLESA cross-sectional analysis of the short-term outcomes of patients receiving prehospital
treatment for symptomatic hypoglycaemia in Cape Town* Correspondence to Mohamed Ridhaa Booley. Mohammed.Booley@
westerncape.gov.za
Peer review under responsibility of African Federation for Emergency Medicine.
Production and hosting by Elsevier
http://dx.doi.org/10.1016/j.afjem.2015.03.003
2211-419X ª 2015 African Federation for Emergency Medicine. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Analyse transversale des re´sultats a` court terme concernant les patients se voyant administrer un
traitement pre´hospitalier en cas d’hypoglyce´mie symptomatique au Cap
Mohamed Ridhaa Booley a,*, Tyson Welzel b
a Western Cape Government – Health – Emergency Medical Services, South Africa
b Division of Emergency Medicine, University of Cape Town, South Africa
Received 26 January 2015; revised 17 March 2015; accepted 17 March 2015; available online 23 May 2015
Introduction: There has been a growing prevalence of patients with chronic medical conditions in South Africa, diabetes mellitus being one of them. Acute symp-
tomatic hypoglycaemia (SH) refers to decreased level of plasma glucose <3.5 mmol/L accompanied by an altered level of consciousness. Pre-hospital management
of such episodes includes reversal by oral and/or intravenous glucose administration, or intramuscular glucagon administration. Post-reversal, patients may refuse
transport to hospital, which may result in recurrent episodes of acute SH. The aim of this study was to retrospectively determine the outcomes of adult SH patients
who were treated and discharged pre-hospital.
Methods: A retrospective cross-sectional study design was used. Patient report forms from patients with SH managed in the pre-hospital setting between May 2012 and
September 2012 in the greater Cape Town area were extracted from the Emergency Medical Services (EMS) database. A follow-up survey using a closed-ended
questionnaire was administered to these same patients within seven days post-reversal to evaluate the efﬁcacy of pre-hospital discharge of SH patients.
Results: A total of 110 eligible patients were identiﬁed and telephonically interviewed. It was found that 21 (19%) of cases had subsequently died. Of the 89 remaining
cases, 30 (34%) reactivated EMS within seven days of discharge, independent of SH being the chief complaint. In total, 48 (54%) had recurrent episodes of SH within
seven days of discharge by EMS. In 47 (53%) of cases discharged by EMS, no follow-up instructions were provided to mitigate recurrent SH episodes or complications.
Conclusion: More than half of patients who received pre-hospital treatment and discharge for SH had recurrent symptoms post-reversal by EMS staff, with a third
needing to reactivate EMS. This would suggest that the current strategy of dealing with such cases needs careful re-evaluation to improve the quality of management of
this patient population.Introduction: Une pre´valence croissance de patients souffrant de proble`mes de sante´ chroniques en Afrique du Sud a e´te´ observe´e, dont le diabe`te de type 2.
L’hypoglyce´mie symptomatique aigue¨ (HS) fait re´fe´rence a` une re´duction du niveau de glucose plasmatique a` moins de 3,5 mmol/l, accompagne´e d’un niveau de con-
science alte´re´. La prise en charge pre´hospitalie`re de ces e´pisodes inclut l’inversion de cette tendance par l’administration de glucose par voie orale et/ou intraveineuse, ou
l’administration de glucagon par voie intramusculaire. Une fois la situation re´tablie, les patients peuvent refuser d’eˆtre transporte´s jusqu’a` l’hoˆpital, ce qui peut re´sulter
sur la re´currence d’e´pisodes de HS aigue¨. L’objectif de cette e´tude e´tait de de´terminer de manie`re re´trospective les re´sultats en pre´hospitalier, concernant les patients
souffrant de HS traite´s et de´charge´s.
Me´thodes: Un plan d’e´tude transversale et re´trospective a e´te´ utilise´. Les formulaires de compte-rendu des patients souffrant de HS pris en charge en pre´hospitalier
entre mai 2012 et septembre 2012 dans la re´gion de la me´tropole du Grand Cap ont e´te´ extraits de la base de donne´es des services me´dicaux d’urgence. Une enqueˆte de
suivi, utilisant un questionnaire a` questions ferme´es, a e´te´ soumise aux meˆmes patients dans les sept jours suivant le traitement aﬁn d’e´valuer l’efﬁcacite´ de la de´charge
pre´hospitalie`re des patients souffrant de HS.
Re´sultats: Au total, 110 patients e´ligibles ont e´te´ identiﬁe´s et interroge´s par te´le´phone. Au total, 21 patients (19%) sont de´ce´de´s par la suite. Sur les 89 cas restants, 30
patients (34%) ont recontacte´ les SMU dans les sept jours suivant leur de´charge, que la HS ait e´te´ ou non la principale cause de l’intervention. Au total, 48 patients
(54%) ont souffert d’e´pisodes de HS re´currents dans les sept jours suivant leur de´charge par les SMU. Dans 47 cas (53%) de de´charge par les SMU, aucune instruction
de suivi n’a e´te´ fournie pour atte´nuer les e´pisodes re´currents ou complications de HS.
Conclusion: Plus de la moitie´ des patients qui s’e´taient vus administrer un traitement pre´hospitalier et de´charge´s suite a` une HS souffraient de symptoˆmes re´currents
une fois la situation re´tablie par le personnel des SMU, un tiers ayant besoin de recontacter les SMU. Ce qui sugge´rerait que la strate´gie actuelle du traitement de ces cas
doit faire l’objet d’une re´e´valuation soigne´e aﬁn d’ame´liorer la qualite´ de la prise en charge de cette population de patients.African relevance
 In Africa, pre-hospital symptomatic hypoglycaemia is
common in diabetics and is often coupled with
resource-conﬁned environments for the required treatment.
160 M. Ridhaa Booley, T. Welzel This article suggests that the practice of pre-hospital dis-
charge post-symptomatic hypoglycaemia may result in
recurrent episodes, which in turn may be associated with
an increase in morbidity and mortality.
 There is a lack of follow-up information provided by EMS
practitioners to patients after pre-hospital discharge follow-
ing treatment for symptomatic hypoglycaemia.
Introduction
South African state Emergency Medical Services (EMS) serve
as an entry point into the health system for the majority of the
population, particularly in historically disadvantaged commu-
nities. Over the past decade, there has been a growing preva-
lence of patients with chronic medical conditions such as
heart disease, diabetes mellitus, hypertension, and infectious
diseases.1 Amongst patients known to have diabetes, this has
resulted in increased EMS calls for patients presenting with
symptomatic hypoglycaemia (SH).
In the South African EMS context, SH is deﬁned as a blood
glucose of less than 3.5 mmol/L presenting with an altered
level of consciousness.2 There are multiple underlying causes
and potentiating factors that may precipitate or exacerbate
SH. Over a longer term, SH, especially if recurrent, may lead
to increased morbidity and mortality.3 Even though the three
levels of pre-hospital care – basic (BLS), intermediate (ILS),
and advanced life support (ALS) – provide differing levels of
intervention, by protocol they are all obligated to transport a
patient to the hospital unless they refuse. However, anecdo-
tally, this refusal is usually strongly based on the follow-up
information provided by the provider. Pre-hospital manage-
ment of SH includes immediate reversal strategies and avail-
able paramedics either discharging patients post-reversal or
transporting them to the hospital, based on the patient’s pref-
erence. In cases where a paramedic is unavailable, ILS and
BLS practitioners may discharge the patient if they refuse
further care.
South African pre-hospital emergency care providers have
three pharmaceutical agents available to reverse low plasma
glucose levels, namely: oral glucose, intravenous dextrose,
and glucagon. This aligns with national protocols as set out
by the Health Professions Council of South Africa.2,3 The
pre-hospital environment is limited in terms of diagnostic
capabilities. Consequently, the practitioner is not in a position
to necessarily identify the cause of the SH they are treating.
Furthermore, no formal ‘‘treat and discharge’’ protocols exist
within the Western Cape EMS.
The aim of this study was to determine the outcome of a
sample of adult SH patients who were treated and discharged
pre-hospital, without being brought to an Emergency Centre
for further care. The primary objective was to determine the
number of SH patients who experienced a repeat episode of
hypoglycaemia after discharge and made a repeat call to
EMS for a subsequent episode of SH within seven days of
the primary event. A secondary objective was to determine if
hospital admission was required subsequent to the index epi-
sode of SH. In addition, this study also assessed if emergency
care providers gave follow-up or educational information
during discharge.Methods
The patients for this study were selected from the Northern,
Southern, and Western districts of Cape Town, South
Africa, in alignment with the Western Cape EMS districts.
These patients were identiﬁed from the Western Cape EMS
district database system. This database is updated daily by
data captures from patient care report forms. Data ﬁelds
include case types, response and mission times, clinical assess-
ment, and interventions with disposition methods.
A retrospective cross-sectional study design was used.
Patient report forms for patients with a primary or secondary
diagnosis of SH between May 2012 and September 2012 were
extracted from the EMS database, yielding a convenience sam-
ple of 110 consecutive eligible SH cases. A telephonic follow-
up survey based on a closed-ended questionnaire was con-
ducted within seven days of the initial reversal to evaluate
the outcome of the pre-hospital discharge.
This study included all adult (over 18 years of age) SH
patients with a documented blood glucose level less than
3.5 mmol/L and a reduced level of consciousness. Study partic-
ipants were matched to these criteria using a check sheet,
which also served as a quality assurance intervention to the
study. Blood glucose levels were determined by glucose moni-
tors (i.e., no colorimetric visualisation methods allowed).
Patients must have been discharged in the pre-hospital envi-
ronment post-reversal using oral and/or intravenous and/or
intramuscular hyperglycaemic agents. SH patients outside
the Western, Southern, and Northern Districts were excluded,
as were Cape Town Fire and Rescue Service cases, private sec-
tor EMS cases, and inter-facility transfers. During the tele-
phonic interview, patients unable to speak and understand
English, Afrikaans, or Xhosa were excluded, as these represent
the most common languages spoken in the Western Cape.
Patient report forms with illegible or absent patient and/or
next of kin data were also excluded.
A protocol existed for contacting patients and/or their next
of kin in a systematic manner for up to three tries, after which
they were regarded as non-contactable. The telephonic surveys
were conducted by the principal investigator and a trained sec-
ondary reviewer in English, Afrikaans, or Xhosa, dependent
on the patient’s language preference. The interviews were con-
ducted off a script that was available in all three languages fol-
lowing forwards and backwards translation for accuracy.
Fig. 1 outlines the sampling process.
Results
110 SH patients were eligible for a telephonic interview. Of
note, speaking to third parties, 21 (19%) of the original cases
were subsequently found to have died following the initial
EMS activation and were therefore unavailable for the survey.
The scope of this survey did not allow for the investigation of
the presumed causes of death in these patients. The breakdown
of cases is shown in Table 1. Of speciﬁc interest is the mean age
of 56 years (SD = 13) for this cohort and that cases were
almost equally distributed between males and females.
Of the contactable 89 cases, 54 (61%) had subsequent
recurrent episode/s of SH within seven days of discharge by
Figure 1 Flowchart of outcome sample.
Table 1 Demographics and characteristics of cases studied.
Characteristic Value
N 110
Age* (years) 56 (30–83)
Sex (male/female) 59 (54%)/51 (46%)
Deceased 21 (19%)
Level of prehospital care provided (including deceased cases):
BLS 39 (35%)
ILS 56 (51%)
ALS 15 (14%)
* Median (range) values.
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same time period (Fig. 2). This was independent of SH being
the chief complaint and of motivation for re-activation of
EMS.
Cases with a recurrent episode of SH were noted to use the
following chronic diabetic medications: 12 (23%) oral diabetic
agents only, 26 (50%) insulin only, and 14 (27%) both oralFigure 2 Recurrent symptomatic hypoglycaemic (SHagents and insulin, with 36 (41%) of the 89 eligible patients
not using any medication at the time of the incident.
Hospital admission within seven days post EMS discharge
was required for 46 of the 89 SH cases (52%). The reasons
for admission included infections (21%), hypoglycaemia
(9%), uncontrolled hypertension (6%), cerebrovascular acci-
dents (6%), and hyperglycaemia (10%), all of which may be
linked to underlying diabetes mellitus.
Prior to discharge following SH reversal, 35 (39%) of
patients recall receiving follow-up or other patient informa-
tion. Seven (8%) of patients were either unable to recall the
information or whether this information was even provided.
Fig. 3 stratiﬁes recurrent SH episodes and provision of
follow-up instructions by the levels of provided pre-hospital
care. Notably, there were recurrent SH episodes amongst all
levels of care, despite the provision of instructions. Of the 35
BLS, 45 ILS, and 13 ALS managed cases, 21 (60%), 24
(53%), and 9 (75%) had recurrent episodes, respectively, and
thus required further intervention. Across all 89 cases, 59
(66%) reactivated EMS within seven days of the index pre-
hospital discharge.) episodes within seven days post EMS discharge.
Figure 3 Recurrent acute SH episodes and provision of follow-up instructions across varying levels of pre-hospital care.
162 M. Ridhaa Booley, T. WelzelIt was also found that post-discharge after SH reversal,
patients had experienced the following abnormal signs and
symptoms: headaches with or without dizziness 30 (27%),
increased levels of sweating 15 (14%), abdominal discomfort
14 (13%), nausea and vomiting 12 (11%), and weakness and
confusion 9 (8%). These symptoms are highly suggestive of
recurrent SH episodes.
Discussion
Symptomatic hypoglycaemia is considered a serious complica-
tion of diabetes mellitus. SH may be disease-induced or precip-
itated by single or multiple medications used in combination.3
The treatment of pre-hospital SH is often limited to short term
management strategies, with minimal capacity for the detec-
tion or treatment of underlying pathologies contributing to
the index event.3,9
This study suggests that recurrent SH episodes are associ-
ated with the reactivation of EMS resources. The decision to
discharge a patient immediately after reversal in the pre-
hospital environment is often motivated by patient refusal of
hospital admission and further care.4 These requests cannot
be denied on the basis of patient autonomy and legal rights.
However, a large number of cases eventually reactivated
EMS within the study period. Although the precise triggers
for the second calls were not ascertained, several patients
had signs and symptoms suggestive of repeat SH episodes.
The outcomes of this study may be compared to a 1998
prospective descriptive study from the USA evaluating the
short-term outcomes of acute SH patients after discharge.
That study showed that 91% of cases had recurrent episodes
within 72 h, with 9% of these cases reactivating EMS.4
Though the recurrence rate was higher in the US study, reac-
tivation of EMS was higher in our local cohort. Within our
context, this could be attributed to poor socio-economic
circumstances and reduced access to deﬁnitive care.Within the Western Cape EMS, providers utilise blood glu-
cose monitors as part of their scope of practice. These moni-
tors have inherent limitations as they usually require
calibration, a quality assurance step that is often not per-
formed.3 Test strip accuracy may be inﬂuenced by expiration,
extreme temperature ﬂuctuations, and humidity. These factors
may lead to under- or over-detected blood glucose levels,
which inﬂuence treatment and discharge strategies.7
In BLS cases or in cases where intravenous access cannot be
established, oral hyperglycaemic agents are administered.
These agents are short acting and may require a longer period
of time to achieve the desired blood glucose level, thus poten-
tiating neurological fallout.11 This effect may be partly respon-
sible for data seen in this study, where 60% of the BLS cases
experienced recurrent episodes, as oral glucose may have
resulted in premature discharge. Current South African pre-
hospital ILS and ALS protocols for the management of acute
SH patients include the administration of intravenous dextrose
50%, intramuscular or intravenous glucagon, and oral anti-
hypoglycaemic agents.13 The current dextrose dosage results
in a faster time to achieve normoglyceamia. However, high
concentration dextrose may induce hyperglycaemia in the
short term and/or result in renewed hypoglycaemia in the
longer term.16 This phenomenon may also have played a role
in this study, in which 53% of ILS cases and 75% of ALS cases
experienced recurrent episodes of SH. An additional treatment
is the biosynthetic form of glucagon, which increases blood
glucose by stimulating its release from the liver by the process
of glycogenolysis.11 However, this method is dependent upon
adequate endogenous glucose stores, which may already be
exhausted due to repeated episodes of hypoglycaemia, starva-
tion, extensive liver damage, or adrenal insufﬁciency.11 These
factors are often unknown to pre-hospital providers.
Within the Western Cape EMS system, SH patients are pri-
marily discharged if they refuse further care or show normali-
sation of blood glucose levels and a return to their normal level
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practices are not sensitive to risk mitigation, as they are not
tempered by underlying causative factors. Recurrent SH epi-
sodes may also be linked to medication usage, with speciﬁc
emphasis on self-administered insulin and dose related errors.7
Common oral agents such as the sulfonylureas, metformin,
and antibiotics have also been shown to potentiate SH.8–10
The increased rates of subsequent SH episodes and EMS reac-
tivation shown in this study may have been linked to inade-
quate dosing of these agents and concomitant medication
usage. In support of this, recurrent SH was especially evident
in patients using insulin when compared to oral diabetic agent
use only. This pattern is supported by a recent systematic
review stating that 47% of a group of 267 patients treated with
insulin presented with recurrent SH episodes.17,18
Current levels of prehospital care with the Western Cape
EMS include BLS, ILS, and ALS, with the vast majority of
practitioners only having BLS and ILS training. BLS and
ILS practitioners primarily treated patients included in this
study. This may have posed a signiﬁcant risk to patients due
to the limited capabilities of these practitioners.12,14 This study
showed that only 29% of BLS patients, 42% of ILS patients,
and 33% of ALS patients were given information and
follow-up instructions, potentially contributing to the ﬁndings
of recurrent SH episodes in 60% of BLS patients, 53% of ILS
patients, and 75% of ALS patients. Patient outcomes may also
have been independent of information provided. It is noted
that in some cases where instructions were known to be ver-
bally provided, patients were unable to recall such informa-
tion. The manner in which providers provided any
information, or whether it was inﬂuenced by poor cognitive
states post-SH reversal remains uncertain.5 Decreased levels
of plasma glucose result in sympatho-adrenal nervous system
stimulation, and subsequent further drops in glucose may
result in an increase in mortality and morbidity.
Consequently, multiple recurrent SH episodes increase the risk
for neurological deﬁcits with resultant long term local and sys-
temic morbidities.6 Furthermore, these neurological deﬁcits
may affect cognitive function and thus the patient’s ability to
reason and make adequate decisions around further care
strategies.7 This is not usually considered in the pre-hospital
discharge process, and thus becomes a concern in this study
population.
Follow-up care instructions play a key role in the safe dis-
position and discharge of patients, particularly in the pre-
hospital context. These instructions should ideally be in writ-
ing, evidence-based, and vetted against patient outcomes (as
demonstrated in Appendix A). They should also include stan-
dardised information cards for the patient or bystanders to
identify early signs and symptoms of recurrent SH. Criteria
may also be linked to differential underlying pathologies upon
which the patient, bystanders, or practitioners may act appro-
priately. However, a disadvantage of this may be the inability
of some patients to interpret this information, in some cases
due to the chronic complications of diabetes mellitus such as
inadequate vision.
Subsequent to repeat activation of EMS after initial dis-
charge, 52% of the study patients required hospitalisation.
In a similar study conducted in 2008, 199 acute SH patients
were followed after pre-hospital discharge after reversal of
hypoglycaemia. In this group, 16% required hospital admis-
sion.15 It was also noted that severe cases of hypoglycaemiawere shown to have an 18% recurrence rate within a 48-h per-
iod. In another recent cohort study it was shown that patients
with recurrent SH had extended hospital stays, increased mor-
bidity, and an increased need for specialised nursing.19 A
recent review of cost impact per patient presenting with hypo-
glycaemia in Spain described that a single episode may cost in
excess of €3500 (ZAR 52,500 at current exchange rates).20
Thus, repeat SH episodes may prove to be very costly for
patients and funders. A major compounding factor is that of
quality of life for patients experiencing long-term effects from
recurrent SH episodes.
Though this study was not designed to further explore the
causative factors leading up to death, a high proportion of
SH cases initially discharged were found to have died upon
telephonic follow-up. Further, it may be that a number of
the patients who did not respond to the telephonic challenge
might also have died. The contribution of SH disposition strat-
egy to overall mortality remains speculative. There may be a
link between misdiagnoses or inabilities to detect underlying
causes of SH and mortality in this cohort. Furthermore, med-
ication administration and interactions may have increased
mortality in this group.
This study population was limited to three Metropole EMS
divisions, so data cannot necessarily be extrapolated to the
remainder of the Western Cape population. However, as
detailed, these divisions are fairly typical and major differences
at least within the Western Cape are not expected. A major dif-
ﬁculty encountered in data collection was the identiﬁcation of
pure SH cases, often due to ambivalent data. A further limita-
tion was the exclusion of data from Fire Services, private EMS
agencies, inter-hospital transfers, and other ﬁrst responders.
There was likely also a degree of recall bias during the tele-
phonic interview, though this was hopefully limited by using
the seven-day time limit for interviews to be done. A detailed
analysis of time sequences in both prior and post- index SH
episodes relative to underlying co-morbidities was not possi-
ble. With reference to the need for hospital admission post-
SH reversal, the diagnosis provided by patients or relatives
may not have been on the causal pathway from the index
SH episode. For deceased cases, a detailed analysis of causal
pathways and associations with the index SH episode was
not possible with the study methodology employed. This study
also lacked a control group measuring the rate of recurrent vis-
its to Emergency Centres and EMS callouts.
Conclusion
A determination of underlying causative factors is a vital part
of the treatment of SH. Even in this small study, 52% of
patients required hospitalisation following initial treatment
and pre-hospital discharge for an episode of SH. More effec-
tive ‘‘treat and discharge’’ protocols should be developed to
reduce repeat episodes, repeat EMS calls, and mitigate risks.
These protocols should use a systematic approach to the man-
agement of acute SH for all levels of pre-hospital care provi-
ders. Risk stratiﬁcation tools should be included. These
mitigation strategies may also reduce the development and
progression of co-morbidities and should be developed in con-
junction with hospital-based Emergency Centres that also treat
these patients. Currently, no evidence exists on the long and
short-term outcomes of the implementation of such strategies.
164 M. Ridhaa Booley, T. WelzelThis is of importance in the Western Cape and South Africa as
a whole.
Comprehensive and understandable education is an impor-
tant treatment component when considering pre-hospital dis-
charge of any patient, though a consistent relationship
between providing information and recurrent SH episodes
was not seen in this particular study. Effective patient and rel-
ative information cards should be developed and implemented
to enable the patient and their family to make informed
choices regarding follow-up and emergency care.
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